NAD | NUV | NAD / NUV | |
Gain YTD | -0.297 | 2.068 | -14% |
Net Assets | 2.67B | 1.83B | 146% |
Total Expense Ratio | 1.41 | 0.47 | 300% |
Turnover | 18.00 | 21.00 | 86% |
Yield | 5.32 | 4.22 | 126% |
Fund Existence | 26 years | 38 years | - |
NAD | NUV | |
---|---|---|
RSI ODDS (%) | 3 days ago44% | 3 days ago70% |
Stochastic ODDS (%) | 3 days ago80% | 3 days ago82% |
Momentum ODDS (%) | 3 days ago59% | 3 days ago69% |
MACD ODDS (%) | 3 days ago63% | 3 days ago76% |
TrendWeek ODDS (%) | 3 days ago64% | 3 days ago70% |
TrendMonth ODDS (%) | 3 days ago77% | 3 days ago74% |
Advances ODDS (%) | 13 days ago77% | 3 days ago76% |
Declines ODDS (%) | 4 days ago72% | 5 days ago76% |
BollingerBands ODDS (%) | 3 days ago79% | 3 days ago83% |
Aroon ODDS (%) | 3 days ago67% | 3 days ago70% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVIX | 10.10 | 0.06 | +0.60% |
American Century Small Cap Value Inv | |||
VITSX | 152.68 | 0.67 | +0.44% |
Vanguard Total Stock Market Idx I | |||
GCLLX | 17.21 | 0.06 | +0.35% |
Goldman Sachs Enhanced U.S. Equity C | |||
VECRX | 22.33 | 0.07 | +0.31% |
Virtus KAR Equity Income R6 | |||
FBTTX | 25.58 | N/A | N/A |
Fidelity Advisor Biotechnology M |